Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 744

1.

Elevated plasmin(ogen) as a common risk factor for COVID-19 susceptibility.

Ji HL, Zhao R, Matalon S, Matthay MA.

Physiol Rev. 2020 Mar 27. doi: 10.1152/physrev.00013.2020. [Epub ahead of print]

PMID:
32216698
2.

Acute respiratory distress syndrome-attributable mortality in critically ill patients with sepsis.

Auriemma CL, Zhuo H, Delucchi K, Deiss T, Liu T, Jauregui A, Ke S, Vessel K, Lippi M, Seeley E, Kangelaris KN, Gomez A, Hendrickson C, Liu KD, Matthay MA, Ware LB, Calfee CS.

Intensive Care Med. 2020 Mar 23. doi: 10.1007/s00134-020-06010-9. [Epub ahead of print]

PMID:
32206845
3.

Treatment for severe acute respiratory distress syndrome from COVID-19.

Matthay MA, Aldrich JM, Gotts JE.

Lancet Respir Med. 2020 Mar 20. pii: S2213-2600(20)30127-2. doi: 10.1016/S2213-2600(20)30127-2. [Epub ahead of print] No abstract available.

PMID:
32203709
4.

Identifying Clinical Research Priorities in Adult Pulmonary and Critical Care: NHLBI Working Group Report.

Semler MW, Bernard GR, Aaron SD, Angus DC, Biros MH, Brower RG, Calfee CS, Colantuoni EA, Ferguson ND, Gong MN, Hopkins RO, Hough CL, Iwashyna TJ, Levy BD, Martin TR, Matthay MA, Mizgerd JP, Moss M, Needham DM, Self WH, Seymour CW, Stapleton RD, Thompson BT, Wunderink RG, Aggarwal NR, Reineck LA.

Am J Respir Crit Care Med. 2020 Mar 9. doi: 10.1164/rccm.201908-1595WS. [Epub ahead of print]

PMID:
32150460
5.

Plasmin improves oedematous blood-gas barrier by cleaving epithelial sodium channels.

Zhao R, Ali G, Nie HG, Chang Y, Bhattarai D, Su X, Zhao X, Matthay MA, Ji HL.

Br J Pharmacol. 2020 Mar 4. doi: 10.1111/bph.15038. [Epub ahead of print]

PMID:
32133621
6.

Patterns and Trends in Advance Care Planning Among Older Adults Who Received Intensive Care at the End of Life.

Block BL, Jeon SY, Sudore RL, Matthay MA, Boscardin WJ, Smith AK.

JAMA Intern Med. 2020 Mar 2. doi: 10.1001/jamainternmed.2019.7535. [Epub ahead of print] No abstract available.

PMID:
32119031
7.

Extracellular Vesicles: A New Frontier for Research in Acute Respiratory Distress Syndrome.

Mahida RY, Matsumoto S, Matthay MA.

Am J Respir Cell Mol Biol. 2020 Feb 28. doi: 10.1165/rcmb.2019-0447TR. [Epub ahead of print]

PMID:
32109144
8.

Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop.

Harhay MO, Casey JD, Clement M, Collins SP, Gayat É, Gong MN, Jaber S, Laterre PF, Marshall JC, Matthay MA, Monroe RE, Rice TW, Rubin E, Self WH, Mebazaa A.

Intensive Care Med. 2020 Feb 18. doi: 10.1007/s00134-020-05934-6. [Epub ahead of print]

PMID:
32072303
9.

Potential Value of Biomarker Signatures in Sepsis and Acute Respiratory Distress Syndrome in Children and Adults.

Hendrickson CM, Matthay MA.

Crit Care Med. 2020 Mar;48(3):428-430. doi: 10.1097/CCM.0000000000004169. No abstract available.

PMID:
32058380
10.

Gender Differences in Authorship of Critical Care Literature.

Vranas KC, Ouyang D, Lin AL, Slatore CG, Sullivan DR, Prasad Kerlin M, Liu KD, Baron RM, Calfee CS, Ware LB, Halpern S, Matthay MA, Herridge M, Mehta S, Rogers AJ.

Am J Respir Crit Care Med. 2020 Jan 22. doi: 10.1164/rccm.201910-1957OC. [Epub ahead of print]

PMID:
31968182
11.

Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials.

Sinha P, Delucchi KL, McAuley DF, O'Kane CM, Matthay MA, Calfee CS.

Lancet Respir Med. 2020 Mar;8(3):247-257. doi: 10.1016/S2213-2600(19)30369-8. Epub 2020 Jan 13.

PMID:
31948926
12.
13.

The authors reply.

Rogers AJ, Desai M, Matthay MA, Choi AM, Baron RM.

Crit Care Med. 2020 Jan;48(1):e78. doi: 10.1097/CCM.0000000000004081. No abstract available.

PMID:
31833991
14.

Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study.

Anderson BJ, Calfee CS, Liu KD, Reilly JP, Kangelaris KN, Shashaty MGS, Lazaar AL, Bayliffe AI, Gallop RJ, Miano TA, Dunn TG, Johansson E, Abbott J, Jauregui A, Deiss T, Vessel K, Belzer A, Zhuo H, Matthay MA, Meyer NJ, Christie JD.

Crit Care. 2019 Dec 9;23(1):400. doi: 10.1186/s13054-019-2684-2.

15.
16.

The value of kinetic glomerular filtration rate estimation on medication dosing in acute kidney injury.

Kwong YD, Chen S, Bouajram R, Li F, Matthay MA, Mehta KM, Glidden DV, Liu KD.

PLoS One. 2019 Nov 26;14(11):e0225601. doi: 10.1371/journal.pone.0225601. eCollection 2019.

17.

Proliferative regulation of alveolar epithelial type 2 progenitor cells by human Scnn1d gene.

Zhao R, Ali G, Chang J, Komatsu S, Tsukasaki Y, Nie HG, Chang Y, Zhang M, Liu Y, Jain K, Jung BG, Samten B, Jiang D, Liang J, Ikebe M, Matthay MA, Ji HL.

Theranostics. 2019 Oct 18;9(26):8155-8170. doi: 10.7150/thno.37023. eCollection 2019.

18.

Peripheral blood leukocyte telomere length is associated with survival of sepsis patients.

Liu S, Wang C, Green G, Zhuo H, Liu KD, Kangelaris KN, Gomez A, Jauregui A, Vessel K, Ke S, Hendrickson C, Matthay MA, Calfee CS, Ware LB, Wolters PJ.

Eur Respir J. 2020 Jan 16;55(1). pii: 1901044. doi: 10.1183/13993003.01044-2019. Print 2020 Jan.

PMID:
31619475
19.

Lung inflammatory environments differentially alter mesenchymal stromal cell behavior.

Abreu SC, Rolandsson Enes S, Dearborn J, Goodwin M, Coffey A, Borg ZD, Dos Santos CC, Wargo MJ, Cruz FF, Loi R, DeSarno M, Ashikaga T, Antunes MA, Rocco PRM, Liu KD, Lee JW, Matthay MA, McKenna DH, Weiss DJ.

Am J Physiol Lung Cell Mol Physiol. 2019 Dec 1;317(6):L823-L831. doi: 10.1152/ajplung.00263.2019. Epub 2019 Sep 25.

20.

Clinically relevant model of pneumococcal pneumonia, ARDS, and nonpulmonary organ dysfunction in mice.

Gotts JE, Bernard O, Chun L, Croze RH, Ross JT, Nesseler N, Wu X, Abbott J, Fang X, Calfee CS, Matthay MA.

Am J Physiol Lung Cell Mol Physiol. 2019 Nov 1;317(5):L717-L736. doi: 10.1152/ajplung.00132.2019. Epub 2019 Sep 11.

PMID:
31509438
21.

Plasma sRAGE Acts as a Genetically Regulated Causal Intermediate in Sepsis-associated Acute Respiratory Distress Syndrome.

Jones TK, Feng R, Kerchberger VE, Reilly JP, Anderson BJ, Shashaty MGS, Wang F, Dunn TG, Riley TR, Abbott J, Ittner CAG, Christiani DC, Mikacenic C, Wurfel MM, Ware LB, Calfee CS, Matthay MA, Christie JD, Meyer NJ.

Am J Respir Crit Care Med. 2020 Jan 1;201(1):47-56. doi: 10.1164/rccm.201810-2033OC.

PMID:
31487195
22.

Therapeutic Effects of Hyaluronic Acid in Bacterial Pneumonia in Ex Vivo Perfused Human Lungs.

Liu A, Park JH, Zhang X, Sugita S, Naito Y, Lee JH, Kato H, Hao Q, Matthay MA, Lee JW.

Am J Respir Crit Care Med. 2019 Nov 15;200(10):1234-1245. doi: 10.1164/rccm.201812-2296OC.

PMID:
31390880
23.

Association of Elevated Plasma Interleukin-18 Level With Increased Mortality in a Clinical Trial of Statin Treatment for Acute Respiratory Distress Syndrome.

Rogers AJ, Guan J, Trtchounian A, Hunninghake GM, Kaimal R, Desai M, Kozikowski LA, DeSouza L, Mogan S, Liu KD, Matthay MA, Steingrub J, Wheeler A, Yoon JH, Nakahira K, Choi AM, Baron RM.

Crit Care Med. 2019 Aug;47(8):1089-1096. doi: 10.1097/CCM.0000000000003816.

PMID:
31206358
24.

The ex vivo human lung: research value for translational science.

Ross JT, Nesseler N, Lee JW, Ware LB, Matthay MA.

JCI Insight. 2019 Jun 6;4(11). pii: 128833. doi: 10.1172/jci.insight.128833. eCollection 2019 Jun 6. Review.

25.

Pulmonary Dead Space Monitoring: Identifying Subjects With ARDS at Risk of Developing Right Ventricular Dysfunction.

Papolos AI, Schiller NB, Belzer A, Zhuo H, Gotts JE, Bibby D, Calfee CS, Matthay MA.

Respir Care. 2019 Sep;64(9):1101-1108. doi: 10.4187/respcare.06544. Epub 2019 May 28.

PMID:
31138736
26.

Pathogenesis of Acute Respiratory Distress Syndrome.

Huppert LA, Matthay MA, Ware LB.

Semin Respir Crit Care Med. 2019 Feb;40(1):31-39. doi: 10.1055/s-0039-1683996. Epub 2019 May 6.

PMID:
31060086
27.

A prospective investigation of interleukin-8 levels in pediatric acute respiratory failure and acute respiratory distress syndrome.

Flori H, Sapru A, Quasney MW, Gildengorin G, Curley MAQ, Matthay MA, Dahmer MK; BALI and RESTORE Study Investigators, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network.

Crit Care. 2019 Apr 17;23(1):128. doi: 10.1186/s13054-019-2342-8.

28.

Precision medicine for cell therapy in acute respiratory distress syndrome - Authors' reply.

Matthay MA, Zhuo H, Gotts JE, Liu KD, Calfee CS.

Lancet Respir Med. 2019 Apr;7(4):e14. doi: 10.1016/S2213-2600(19)30083-9. No abstract available.

PMID:
30926051
29.

The authors reply.

Fielding-Singh V, Matthay MA, Calfee CS.

Crit Care Med. 2019 Apr;47(4):e380-e381. doi: 10.1097/CCM.0000000000003666. No abstract available.

PMID:
30882446
30.

The authors reply.

Fielding-Singh V, Matthay MA, Calfee CS.

Crit Care Med. 2019 Apr;47(4):e375-e376. doi: 10.1097/CCM.0000000000003648. No abstract available.

PMID:
30882440
31.

Acute respiratory distress syndrome.

Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, Herridge M, Randolph AG, Calfee CS.

Nat Rev Dis Primers. 2019 Mar 14;5(1):18. doi: 10.1038/s41572-019-0069-0. Review.

32.

Is a Part Better than the Whole for Cell-based Therapy for Acute Respiratory Distress Syndrome?

Lee JW, Matthay MA.

Anesthesiology. 2019 May;130(5):683-685. doi: 10.1097/ALN.0000000000002653. No abstract available.

33.

Heterogeneity in sepsis: new biological evidence with clinical applications.

Leligdowicz A, Matthay MA.

Crit Care. 2019 Mar 9;23(1):80. doi: 10.1186/s13054-019-2372-2. Review.

34.

Positive Cumulative Fluid Balance Is Associated With Mortality in Pediatric Acute Respiratory Distress Syndrome in the Setting of Acute Kidney Injury.

Zinter MS, Spicer AC, Liu KD, Orwoll BE, Alkhouli MF, Brakeman PR, Calfee CS, Matthay MA, Sapru A.

Pediatr Crit Care Med. 2019 Apr;20(4):323-331. doi: 10.1097/PCC.0000000000001845.

PMID:
30672838
35.

ECMO in severe acute respiratory distress syndrome.

Matthay MA.

Lancet Respir Med. 2019 Feb;7(2):106-108. doi: 10.1016/S2213-2600(18)30507-1. Epub 2019 Jan 11. No abstract available.

PMID:
30642777
36.

Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults.

Langelier C, Kalantar KL, Moazed F, Wilson MR, Crawford ED, Deiss T, Belzer A, Bolourchi S, Caldera S, Fung M, Jauregui A, Malcolm K, Lyden A, Khan L, Vessel K, Quan J, Zinter M, Chiu CY, Chow ED, Wilson J, Miller S, Matthay MA, Pollard KS, Christenson S, Calfee CS, DeRisi JL.

Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12353-E12362. doi: 10.1073/pnas.1809700115. Epub 2018 Nov 27.

37.

Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial.

Matthay MA, Calfee CS, Zhuo H, Thompson BT, Wilson JG, Levitt JE, Rogers AJ, Gotts JE, Wiener-Kronish JP, Bajwa EK, Donahoe MP, McVerry BJ, Ortiz LA, Exline M, Christman JW, Abbott J, Delucchi KL, Caballero L, McMillan M, McKenna DH, Liu KD.

Lancet Respir Med. 2019 Feb;7(2):154-162. doi: 10.1016/S2213-2600(18)30418-1. Epub 2018 Nov 16.

PMID:
30455077
38.

Prospective Assessment of the Feasibility of a Trial of Low-Tidal Volume Ventilation for Patients with Acute Respiratory Failure.

Lanspa MJ, Gong MN, Schoenfeld DA, Lee KT, Grissom CK, Hou PC, Serpa-Neto A, Brown SM, Iwashyna TJ, Yealy DM, Hough CL, Brower RG, Calfee CS, Hyzy RC, Matthay MA, Miller RR 3rd, Steingrub JS, Thompson BT, Miller CD, Clemmer TP, Hendey GW, Huang DT, Mathews KS, Qadir N, Tidswell M; The National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network.

Ann Am Thorac Soc. 2019 Mar;16(3):356-362. doi: 10.1513/AnnalsATS.201807-459OC.

39.

The Continued Need for Clinical Trials in Deceased Organ Donor Management.

Niemann CU, Matthay MA, Ware LB.

Transplantation. 2019 Jul;103(7):1298-1299. doi: 10.1097/TP.0000000000002512. No abstract available.

PMID:
30399123
40.

Therapeutic potential of mesenchymal stromal cells in the treatment of ARDS.

Huppert LA, Liu KD, Matthay MA.

Transfusion. 2019 Feb;59(S1):869-875. doi: 10.1111/trf.14835. Epub 2018 Nov 1. No abstract available.

PMID:
30383290
41.

AIMing Immunomodulation Therapy at Sepsis.

Leligdowicz A, Matthay MA.

Am J Respir Cell Mol Biol. 2019 Mar;60(3):253-254. doi: 10.1165/rcmb.2018-0338ED. No abstract available.

PMID:
30365342
42.

Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development: evidence from Mendelian randomization and mediation analysis.

Reilly JP, Wang F, Jones TK, Palakshappa JA, Anderson BJ, Shashaty MGS, Dunn TG, Johansson ED, Riley TR, Lim B, Abbott J, Ittner CAG, Cantu E, Lin X, Mikacenic C, Wurfel MM, Christiani DC, Calfee CS, Matthay MA, Christie JD, Feng R, Meyer NJ.

Intensive Care Med. 2018 Nov;44(11):1849-1858. doi: 10.1007/s00134-018-5328-0. Epub 2018 Oct 21.

43.

Identification of Acute Kidney Injury Subphenotypes with Differing Molecular Signatures and Responses to Vasopressin Therapy.

Bhatraju PK, Zelnick LR, Herting J, Katz R, Mikacenic C, Kosamo S, Morrell ED, Robinson-Cohen C, Calfee CS, Christie JD, Liu KD, Matthay MA, Hahn WO, Dmyterko V, Slivinski NSJ, Russell JA, Walley KR, Christiani DC, Liles WC, Himmelfarb J, Wurfel MM.

Am J Respir Crit Care Med. 2019 Apr 1;199(7):863-872. doi: 10.1164/rccm.201807-1346OC.

PMID:
30334632
44.

Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.

Sinha P, Delucchi KL, Thompson BT, McAuley DF, Matthay MA, Calfee CS; NHLBI ARDS Network.

Intensive Care Med. 2018 Nov;44(11):1859-1869. doi: 10.1007/s00134-018-5378-3. Epub 2018 Oct 5.

45.

Variability in Pediatric Ideal Body Weight Calculation: Implications for Lung-Protective Mechanical Ventilation Strategies in Pediatric Acute Respiratory Distress Syndrome.

Ward SL, Quinn CM, Steurer MA, Liu KD, Flori HR, Matthay MA.

Pediatr Crit Care Med. 2018 Dec;19(12):e643-e652. doi: 10.1097/PCC.0000000000001740.

46.

Beyond Low Tidal Volume Ventilation: Treatment Adjuncts for Severe Respiratory Failure in Acute Respiratory Distress Syndrome.

Fielding-Singh V, Matthay MA, Calfee CS.

Crit Care Med. 2018 Nov;46(11):1820-1831. doi: 10.1097/CCM.0000000000003406. Review.

47.

Pulmonary mechanics and gas exchange characteristics in uncommon etiologies of acute respiratory distress syndrome.

Kallet RH, Ho K, Lipnick MS, Matthay MA.

J Thorac Dis. 2018 Aug;10(8):5030-5038. doi: 10.21037/jtd.2018.07.78.

48.

Physiologic Analysis and Clinical Performance of the Ventilatory Ratio in Acute Respiratory Distress Syndrome.

Sinha P, Calfee CS, Beitler JR, Soni N, Ho K, Matthay MA, Kallet RH.

Am J Respir Crit Care Med. 2019 Feb 1;199(3):333-341. doi: 10.1164/rccm.201804-0692OC.

49.

Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury.

Liu C, Ma Y, Su Z, Zhao R, Zhao X, Nie HG, Xu P, Zhu L, Zhang M, Li X, Zhang X, Matthay MA, Ji HL.

Front Immunol. 2018 Aug 20;9:1898. doi: 10.3389/fimmu.2018.01898. eCollection 2018.

50.

Assessment of industry data on pulmonary and immunosuppressive effects of IQOS.

Moazed F, Chun L, Matthay MA, Calfee CS, Gotts J.

Tob Control. 2018 Nov;27(Suppl 1):s20-s25. doi: 10.1136/tobaccocontrol-2018-054296. Epub 2018 Aug 29.

Supplemental Content

Loading ...
Support Center